Potential roles of microRNAs and ROS in colorectal cancer: Diagnostic biomarkers and therapeutic targets

Jingmei Lin, Chia Chen Chuang, Li Zuo

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

As one of the most commonly diagnosed cancers worldwide, colorectal adenocarcinoma often occurs sporadically in individuals aged 50 or above and there is an increase among younger patients under 50. Routine screenings are recommended for this age group to improve early detection. The multifactorial etiology of colorectal cancer consists of both genetic and epigenetic factors. Recently, studies have shown that the development and progression of colorectal cancer can be attributed to aberrant expression of microRNA. Reactive oxygen species (ROS) that play a key role in cancer cell survival, can also lead to carcinogenesis and cancer exacerbations. Given the rapid accumulating knowledge in the field, an updated review regarding microRNA and ROS in colorectal cancer is necessary. An extensive literature search has been conducted in PubMed/Medline databases to review the roles of microRNAs and ROS in colorectal cancer. Unique microRNA expression in tumor tissue, peripheral blood, and fecal samples from patients with colorectal cancer is outlined. Therapeutic approaches focusing on microRNA and ROS in colorectal cancer treatment is also delineated. This review aims to summarize the newest knowledge on the pathogenesis of colorectal cancer in the hopes of discovering novel diagnostic biomarkers and therapeutic techniques.

Original languageEnglish (US)
Pages (from-to)17328-17346
Number of pages19
JournalOncotarget
Volume8
Issue number10
DOIs
StatePublished - 2017

Fingerprint

Tumor Biomarkers
MicroRNAs
Colorectal Neoplasms
Reactive Oxygen Species
Therapeutics
Neoplasms
PubMed
Epigenomics
Cell Survival
Carcinogenesis
Adenocarcinoma
Age Groups
Biomarkers
Databases

Keywords

  • Colorectal cancer
  • Free radicals
  • MicroRNA
  • ROS
  • Therapeutic targets

ASJC Scopus subject areas

  • Oncology

Cite this

Potential roles of microRNAs and ROS in colorectal cancer : Diagnostic biomarkers and therapeutic targets. / Lin, Jingmei; Chuang, Chia Chen; Zuo, Li.

In: Oncotarget, Vol. 8, No. 10, 2017, p. 17328-17346.

Research output: Contribution to journalReview article

@article{0c6fd4bd8655457d84d6c9c3ca297d90,
title = "Potential roles of microRNAs and ROS in colorectal cancer: Diagnostic biomarkers and therapeutic targets",
abstract = "As one of the most commonly diagnosed cancers worldwide, colorectal adenocarcinoma often occurs sporadically in individuals aged 50 or above and there is an increase among younger patients under 50. Routine screenings are recommended for this age group to improve early detection. The multifactorial etiology of colorectal cancer consists of both genetic and epigenetic factors. Recently, studies have shown that the development and progression of colorectal cancer can be attributed to aberrant expression of microRNA. Reactive oxygen species (ROS) that play a key role in cancer cell survival, can also lead to carcinogenesis and cancer exacerbations. Given the rapid accumulating knowledge in the field, an updated review regarding microRNA and ROS in colorectal cancer is necessary. An extensive literature search has been conducted in PubMed/Medline databases to review the roles of microRNAs and ROS in colorectal cancer. Unique microRNA expression in tumor tissue, peripheral blood, and fecal samples from patients with colorectal cancer is outlined. Therapeutic approaches focusing on microRNA and ROS in colorectal cancer treatment is also delineated. This review aims to summarize the newest knowledge on the pathogenesis of colorectal cancer in the hopes of discovering novel diagnostic biomarkers and therapeutic techniques.",
keywords = "Colorectal cancer, Free radicals, MicroRNA, ROS, Therapeutic targets",
author = "Jingmei Lin and Chuang, {Chia Chen} and Li Zuo",
year = "2017",
doi = "10.18632/oncotarget.14461",
language = "English (US)",
volume = "8",
pages = "17328--17346",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "10",

}

TY - JOUR

T1 - Potential roles of microRNAs and ROS in colorectal cancer

T2 - Diagnostic biomarkers and therapeutic targets

AU - Lin, Jingmei

AU - Chuang, Chia Chen

AU - Zuo, Li

PY - 2017

Y1 - 2017

N2 - As one of the most commonly diagnosed cancers worldwide, colorectal adenocarcinoma often occurs sporadically in individuals aged 50 or above and there is an increase among younger patients under 50. Routine screenings are recommended for this age group to improve early detection. The multifactorial etiology of colorectal cancer consists of both genetic and epigenetic factors. Recently, studies have shown that the development and progression of colorectal cancer can be attributed to aberrant expression of microRNA. Reactive oxygen species (ROS) that play a key role in cancer cell survival, can also lead to carcinogenesis and cancer exacerbations. Given the rapid accumulating knowledge in the field, an updated review regarding microRNA and ROS in colorectal cancer is necessary. An extensive literature search has been conducted in PubMed/Medline databases to review the roles of microRNAs and ROS in colorectal cancer. Unique microRNA expression in tumor tissue, peripheral blood, and fecal samples from patients with colorectal cancer is outlined. Therapeutic approaches focusing on microRNA and ROS in colorectal cancer treatment is also delineated. This review aims to summarize the newest knowledge on the pathogenesis of colorectal cancer in the hopes of discovering novel diagnostic biomarkers and therapeutic techniques.

AB - As one of the most commonly diagnosed cancers worldwide, colorectal adenocarcinoma often occurs sporadically in individuals aged 50 or above and there is an increase among younger patients under 50. Routine screenings are recommended for this age group to improve early detection. The multifactorial etiology of colorectal cancer consists of both genetic and epigenetic factors. Recently, studies have shown that the development and progression of colorectal cancer can be attributed to aberrant expression of microRNA. Reactive oxygen species (ROS) that play a key role in cancer cell survival, can also lead to carcinogenesis and cancer exacerbations. Given the rapid accumulating knowledge in the field, an updated review regarding microRNA and ROS in colorectal cancer is necessary. An extensive literature search has been conducted in PubMed/Medline databases to review the roles of microRNAs and ROS in colorectal cancer. Unique microRNA expression in tumor tissue, peripheral blood, and fecal samples from patients with colorectal cancer is outlined. Therapeutic approaches focusing on microRNA and ROS in colorectal cancer treatment is also delineated. This review aims to summarize the newest knowledge on the pathogenesis of colorectal cancer in the hopes of discovering novel diagnostic biomarkers and therapeutic techniques.

KW - Colorectal cancer

KW - Free radicals

KW - MicroRNA

KW - ROS

KW - Therapeutic targets

UR - http://www.scopus.com/inward/record.url?scp=85014720468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014720468&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14461

DO - 10.18632/oncotarget.14461

M3 - Review article

C2 - 28061475

AN - SCOPUS:85014720468

VL - 8

SP - 17328

EP - 17346

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 10

ER -